Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Industrial Nuclear Co. (INC) is a specialized manufacturer of radioactive sources and radiation delivery systems, serving both the medical oncology and industrial radiography markets. The company is a leading producer of Iridium-192 and Selenium-75 sources, which are essential for brachytherapy cancer treatments and non-destructive testing applications. In early 2024, INC was acquired by BWX Technologies (BWXT), integrating its advanced encapsulation and source manufacturing capabilities into BWXT's medical isotope portfolio. Headquartered in San Leandro, California, the company is widely recognized for its IR-100 gamma radiography projector and a comprehensive suite of remote handling tools. INC plays a critical role in the global supply chain for life-saving oncological procedures and safety-critical industrial inspections.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Industrial Nuclear Co..